Blood or its components may only be used to prepare labile blood products intended for direct therapeutic use if the results of the screening tests provided for in 5° of article D. 1221-6 are negative.
Derogations from the provisions of articles D. 1221-6 and D. 1221-7 may be provided for by order of the Minister for Health, when blood or its components are collected with a view to preparing labile blood products intended for programmed autologous transfusion.
An order of the Minister for Health may provide for : 1° Biological analyses and screening tests to be carried out for the selection of red cell donors intended to stimulate the synthesis of anti-D antibodies in Rh-immunised plasma donors with a view to the preparation of anti-D immunoglobulins; 2° Biological analyses and screening tests to be carried out for the selection of Rh-immunised plasma donors with a view to…
By way of derogation from the provisions of articles D. 1221-6 to D. 1221-8, an order of the Minister for Health lays down the conditions under which, in order to meet overriding therapeutic needs or to take account of the rarity of certain erythrocyte blood groups, labile blood products for direct therapeutic use, prepared from blood or blood components which have not undergone all the tests and analyses mentioned in…
Any blood establishment collecting blood and its components, which prepares labile blood products intended for the preparation of intermediate products or medicinal products derived from blood, is required to apply the tests and analyses referred to in 4° and in b, c, d, e, g and h of 5° of article D. 1221-6 to the corresponding samples. Blood or its components may only be used for the purposes mentioned in…
Blood and its components may only be used to prepare in vitro diagnostic medical devices if the results of the tests and analyses provided for in b, c and d of 5° of Article D. 1221-6 are negative. However, an in vitro diagnostic medical device may be manufactured from a sample containing one or more antibodies or antigens sought by the tests and analyses mentioned in the above paragraph and…
Blood and its components may only be transferred to an educational establishment or vocational training organisation for teaching purposes, to the exclusion of any administration to humans, and on condition that: -the tests and analyses provided for in 5° of article D. 1221-6 have been carried out on each sample; -the results comply with the provisions of article D. 1221-7.
For the purposes of this section, : 1° Distribution of labile blood products: a) The supply of labile blood products by a blood establishment to other blood establishments, health establishments and health cooperation groups authorised to manage a blood depot and manufacturers of health products derived from human blood or its components ; b) The supply of labile blood products between different sites of the same blood establishment. 2° Delivery…
I.-The distribution and supply of labile blood products required by health establishments and health cooperation groups authorised to manage a blood depot are carried out by a single blood establishment, known as the “referent blood establishment”, determined in application of the blood transfusion organisation plan drawn up under the conditions laid down by articles R. 1224-1 to R. 1224-4. II – When changes in fact or in law are likely…
Healthcare establishments store labile blood products intended for direct therapeutic use in units known as blood depots. A blood depot is a unit that stores and dispenses, under the authority of a doctor or pharmacist, labile blood products intended exclusively for administration in the departments of the health establishment, and carries out compatibility tests where necessary. It also stores labile blood products issued by its referral blood establishment for administration…
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Resources
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Useful links
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.
All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.
